SMTL ID : 2hz0.1 (1 other biounit)

Abl kinase domain in complex with NVP-AEG082

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x GIN: 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE(Non-covalent)

GIN.1: 24 residues within 4Å: Chain A: L.21, V.29, A.42, K.44, E.59, V.62, M.63, I.66, L.71, V.72, I.86, T.88, E.89, F.90, M.91, F.132, H.134, L.143, V.152, A.153, D.154, F.155, S.158, L.160 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:L.21, A:V.29, A:K.44, A:E.59, A:V.62, A:I.86, A:T.88, A:F.132, A:L.143, A:L.143, A:D.154, A:F.155, A:L.160 Hydrogen bonds: A:K.44, A:E.59, A:T.88, A:E.89, A:M.91, A:D.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cowan-Jacob, S.W. et al., Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia. ACTA CRYSTALLOGR.,SECT.D (2007)

Release Date

2007-01-16

Peptides

Proto-oncogene tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase ABL1

Related Entries With Identical Sequence